BIM
CLLS

BlackRock Investment Management’s Cellectis CLLS Stock Holding History

BlackRock Investment Management’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-10,200
Closed -$269K – 4105
2015
Q3 		$269K Hold
10,200
– – ﹤0.01% 3191
2015
Q2 		$368K Hold
10,200
– – ﹤0.01% 3197
2015
Q1 		$353K Buy
+10,200
New +$370K ﹤0.01% 3090

Other funds holding CLLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock Investment Management's CLLS Position: Q4 2015 in Review

BlackRock Investment Management sold out of Cellectis (CLLS) in Q4 2015, closing a stake of 10,200 shares — an estimated $269K sold.

BlackRock Investment Management first reported a position in CLLS in Q1 2015 and held it in 3 quarters. The position peaked at $368K in Q2 2015. 48 funds tracked by Wall St. Rank hold CLLS as of Q4 2015.

  • BlackRock Investment Management reported no remaining Cellectis position as of Q4 2015 after selling out during the quarter.
  • BlackRock Investment Management sold 10,200 Cellectis shares in Q4 2015, an estimated $269K.
  • BlackRock Investment Management first reported a position in Cellectis in Q1 2015 and held it in 3 quarters.
  • BlackRock Investment Management's Cellectis position peaked at $368K in Q2 2015.
  • 48 funds tracked by Wall St. Rank held Cellectis as of Q4 2015.

Based on BlackRock Investment Management's 13F filing for Q4 2015, filed 11 Feb 2016.